Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Mesenchymal Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04589754
What this trial is testing

Adriamycin and Ifosfamide Combined With Sintilimab

Who this might be right for
Soft Tissue Sarcoma
Sun Yat-sen University 176
Testing effectiveness (Phase 2)Study completedNCT01764802
What this trial is testing

Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer

Who this might be right for
Ovarian SarcomaOvarian Stromal CancerStage I Uterine Sarcoma+59 more
Ohio State University Comprehensive Cancer Center 100
Early research (Phase 1)WithdrawnNCT02557854
What this trial is testing

HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors

Who this might be right for
RhabdomyosarcomaNeuroblastomaSarcoma+3 more
Theodore Laetsch
Testing effectiveness (Phase 2)Ended earlyNCT05116683
What this trial is testing

ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma

Who this might be right for
LeiomyosarcomaLiposarcoma
Benjamin Izar 4
Not applicableEnded earlyNCT02901405
What this trial is testing

Negative Pressure Dressing Therapy in Soft Tissue Sarcoma Surgery

Who this might be right for
SarcomaWound Infection
NHS Greater Glasgow and Clyde 17
Testing effectiveness (Phase 2)Study completedNCT01210222
What this trial is testing

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+4 more
Gynecologic Oncology Group 35
Not applicableWithdrawnNCT01034566
What this trial is testing

Proton Beam Radiation Therapy in Treating Patients With Retroperitoneal Sarcoma

Who this might be right for
Adult Soft Tissue Sarcoma
Abramson Cancer Center at Penn Medicine
Not applicableStudy completedNCT02833246
What this trial is testing

Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications

Who this might be right for
SarcomaLungSolid Tumor Gastrointestinal
Memorial Sloan Kettering Cancer Center 28
Testing effectiveness (Phase 2)Study completedNCT00948961
What this trial is testing

CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Who this might be right for
Advanced Malignancies
Celldex Therapeutics 70
Testing effectiveness (Phase 2)Study completedNCT00005042
What this trial is testing

SU5416 in Treating Patients With AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma
AIDS Malignancy Consortium
Testing effectiveness (Phase 2)Ended earlyNCT02624388
What this trial is testing

Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)

Who this might be right for
LymphomaChildhood LymphomaSolid Tumor+13 more
University of Virginia 4
Not applicableEnded earlyNCT01882231
What this trial is testing

Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma

Who this might be right for
OsteosarcomaPaget's DiseaseEwing Sarcoma
Vanderbilt-Ingram Cancer Center 6
Not applicableLooking for participantsNCT06789666
What this trial is testing

Digital Art Therapy for Young Cancer Survivors

Who this might be right for
CancerPediatric CancerPediatric Malignancies+2 more
UNC Lineberger Comprehensive Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT00586846
What this trial is testing

Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma

Who this might be right for
Osteosarcoma
Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT03138161
What this trial is testing

SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma

Who this might be right for
Advanced Soft Tissue SarcomaMetastatic Soft Tissue Sarcoma
Sarcoma Oncology Research Center, LLC 250
Not applicableStudy completedNCT02873923
What this trial is testing

Variability of Definitions for Survival Endpoints and Surrogate Properties for OS in Sarcoma Trials: a Meta-analysis

Who this might be right for
Cancer
Institut Bergonié 2,846
Testing effectiveness (Phase 2)Active Not RecruitingNCT03367741
What this trial is testing

Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer

Who this might be right for
Advanced Endometrial CarcinomaMetastatic Endometrial CarcinomaRecurrent Endometrial Carcinoma+2 more
National Cancer Institute (NCI) 82
Testing effectiveness (Phase 2)Study completedNCT00005854
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Fred Hutchinson Cancer Center
Early research (Phase 1)Ended earlyNCT01491594
What this trial is testing

Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia

Who this might be right for
Sarcoma, Soft TissueOsteosarcomaNeoplasms, Connective and Soft Tissue
Duke University 1
Testing effectiveness (Phase 2)WithdrawnNCT05302570
What this trial is testing

Neoadjuvant Short-course Hypofractionated PBT for Non-metastatic RPS

Who this might be right for
Retroperitoneal Sarcoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Next Page